Switch to:
Alexion Pharmaceuticals, Inc. (NAS:ALXN)
EV/EBIT
55.60 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Alexion Pharmaceuticals, Inc.'s enterprise value is $28,117 Mil. Alexion Pharmaceuticals, Inc.'s operating income for the trailing twelve months (TTM) ended in Dec. 2013 was $528 Mil. Therefore, Alexion Pharmaceuticals, Inc.'s EV/EBIT ratio for today is 55.60.

ALXN' s 10-Year EV/EBIT Range
Min: 33   Max: 893.9
Current: 55.6

33
893.9

During the past 13 years, the highest EV/EBIT Ratio of Alexion Pharmaceuticals, Inc. was 893.90. The lowest was 33.00. And the median was 50.50.

ALXN's EV/EBITis ranked lower than
72% of the 468 Companies
in the Global Biotechnology industry.

( Industry Median: 20.00 vs. ALXN: 55.60 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Alexion Pharmaceuticals, Inc.'s enterprise value for the quarter that ended in Dec. 2013 was $24,803 Mil. Alexion Pharmaceuticals, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was $528 Mil. Alexion Pharmaceuticals, Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 was 2.13%.


Definition

Alexion Pharmaceuticals, Inc.'s EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=28116.997/528.01
=53.25

Alexion Pharmaceuticals, Inc.'s current Enterprise Value is $28,117 Mil.
Alexion Pharmaceuticals, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was 116.972 (Mar. 2013 ) + 137.691 (Jun. 2013 ) + 135.275 (Sep. 2013 ) + 138.072 (Dec. 2013 ) = $528 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Alexion Pharmaceuticals, Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Dec. 2013 )=Operating Income (TTM)/Enterprise Value (Q: Dec. 2013 )
=528.01/24803.21164
=2.13 %

Alexion Pharmaceuticals, Inc.'s Enterprise Value for the quarter that ended in Dec. 2013 was $24,803 Mil.
Alexion Pharmaceuticals, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was 116.972 (Mar. 2013 ) + 137.691 (Jun. 2013 ) + 135.275 (Sep. 2013 ) + 138.072 (Dec. 2013 ) = $528 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals, Inc. Annual Data

Jul04Jul05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebit 0.000.000.000.0081.6648.0046.5555.1243.0646.97

Alexion Pharmaceuticals, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebit 56.8655.1266.5362.9057.7943.0637.8933.7143.4046.97
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide